Articles

The latest news for pharma industry insiders.

Pharma Pulse 2/13/25: PwC Report Identifies Top Trends in Pharma, Counseling About Cannabis Use is Crucial & more

The facilities are expected to offer pharma shipment support by addressing time and temperature-specific requirements. 

UPS Welcomes Three New Cross-Dock Plants

Videos

In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, dives into specific areas where FDA investment could have the greatest impact in accelerating approval timelines.

The Value of Workforce Development and Advanced Data Tools

Pharma Pulse 2/12/25: How Uncertainty & Distrust Damage Relationships with Patients, Health of the Biosimilars Industry & more

Trump raises the import tax to 25% on the former—while restoring the latter to 25%—in a move that could potentially take effect on March 4. 

United States Elevates Tariffs on Steel and Aluminum

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jim Shehan, chair of the FDA regulatory practice at Lowenstein Sandler, discusses some of the other specific regulatory updates that drug developers be closely monitoring in the current landscape.

Keeping a Finger on the Regulatory Pulse

Pharma Pulse 2/11/25: Revolutionizing Patient Adherence, What Does ‘Cure’ Really Mean? & more

The agreement is centered around improving cell culture efficiency and CGT quality. 

PHC, CCRM Partner up on Furthering Cell and Gene Therapy Development

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the challenges associated with meeting the FDA’s 2025 CGT forecasted approval goal. 

News